Maria Castro inducted into the 2023 class of the AIMBE College of Fellows
ANN ARBOR, Michigan – Maria G. Castro, Ph.D., R. C. Schneider Collegiate Professor of Neurosurgery and professor of cell and developmental biology at the University of Michigan, was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top 2% of medical and biological engineers. College membership honors those who have made outstanding contributions to "engineering and medicine research, practice or education” and to "the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education."
Castro was nominated, reviewed and elected by peers and members of the College of Fellows “for distinguished contributions to the brain tumor field, development of immune-engineered nanomedicines and gene-therapies for brain cancer; mentoring women and minorities.”
A formal induction ceremony was held during the AIMBE Annual Event at the Renaissance Arlington Capital View Hotel in Arlington, Virginia, on March 27. Castro was inducted along with 140 colleagues who make up the AIMBE College of Fellows Class of 2023.
While most AIMBE Fellows hail from the United States, the College of Fellows has inducted Fellows representing 30 countries. AIMBE Fellows are employed in academia, industry, clinical practice and government.
AIMBE Fellows are among the most distinguished medical and biological engineers including three Nobel Prize laureates, 17 Fellows having received the Presidential Medal of Science and/or Technology and Innovation, and 205 also inducted to the National Academy of Engineering, 105 inducted to the National Academy of Medicine and 43 inducted to the National Academy of Sciences.
AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. AIMBE’s mission is to recognize excellence, advance public understanding, and accelerate medical and biological innovation. No other organization can bring together academic, industry, government, and scientific societies to form a highly influential community advancing medical and biological engineering. AIMBE’s mission drives advocacy initiatives into action on Capitol Hill and beyond.